Milgamma N (Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride)

Benfotiamine, Cyanocobalamin, Pyridoxine Hydrochloride, the active ingredients in Milgamma N, are a vitamin supplement presented as an oral tablet for oral use. They help address vitamin B deficiencies and support nerve health in adults, acting as co‑enzymes in carbohydrate metabolism and neuronal function.

GNH USA supplies Milgamma N as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Milgamma N is manufactured under GMP conditions and is available in bulk and retail packaging.

Milgamma N is used to support vitamin B‑complex pathways and related neuropathic conditions.

- Vitamin B deficiency: restores normal B‑vitamin levels and supports metabolic processes. - Peripheral neuropathy: alleviates symptoms by improving nerve function. - Diabetic neuropathy: contributes to nerve health and may reduce neuropathic discomfort.

Milgamma N is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: transient stomach cramps. - Headache: occasional mild headache. - Diarrhoea: loose stools in a minority of users.

Serious or Rare Side Effects: - Hypersensitivity reaction: rash, swelling, or anaphylaxis. - Severe skin eruption: Stevens‑Johnson‑type reactions. - Hematologic changes: unexplained bruising or low blood counts. - Liver enzyme elevation: abnormal liver function tests. - Worsening neuropathy: rare exacerbation of nerve symptoms.

Before using Milgamma N, consider the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if advised by a physician. - Renal impairment: monitor kidney function and adjust if necessary. - Drug interactions: review all concomitant medications with a pharmacist. - Allergy: avoid if known hypersensitivity to any B‑vitamin component. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Milgamma N may interact with certain medicines; monitoring is advised.

Major Interactions (Avoid): - Methotrexate: may reduce its efficacy. - Phenytoin: increased metabolism may lower vitamin levels. - Levodopa: possible interference with absorption.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics: reduced vitamin absorption. - Iron supplements: competitive uptake may diminish effectiveness. - Proton pump inhibitors: may affect conversion of cyanocobalamin to active forms.